• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估新冠病毒疾病严重程度或死亡的风险因素及其与代谢途径的关系。

Evaluation of risk factors for COVID-19 severity or death and their relationship to metabolic pathways.

作者信息

Marhuenda-Egea F C, Narro-Serrano J

机构信息

Departamento de Agroquímica y Bioquímica, Universidad de Alicante, Spain.

Departamento de Química Física, Universidad de Alicante, Spain.

出版信息

Heliyon. 2023 Mar;9(3):e14161. doi: 10.1016/j.heliyon.2023.e14161. Epub 2023 Feb 28.

DOI:10.1016/j.heliyon.2023.e14161
PMID:36873473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9972677/
Abstract

BACKGROUND

Since the state of alarm was declared due to the COVID-19 pandemic, hospitals have been the main ones in charge of registering the therapeutic follow-up of affected people. The analysis of these data has allowed those different biochemical markers have been identified as predictors of the severity of the disease, but most of the published studies tend to be eminently descriptive and do not propose a biochemical hypothesis to explain the alteration of the results they are showing. Our objective is to recognize the main metabolic processes that are occurring in COVID-19 patients, as well as the identification of clinical parameters that are decisive to predict the severity of the disease.

METHODS

A multivariate analysis was carried out from the clinical parameters collected in the database of the HM hospitals in Madrid, to determine the most relevant variables to predict the severity of the disease. Chemometric methods allow these variables to be obtained by applying a classification strategy with PLS-LDA.

FINDINGS AND INTERPRETATION

The variables that most contribute to separation are age in men and, in both sexes, the concentration of lactate dehydrogenase, urea and C-reactive protein.Oxygen deficiency in the tissues, due to the loss of functionality of the lungs, could be affecting the muscle tissue with special severity. Inflammation and tissue damage is related to increased LDH and CRP. The loss of muscle mass and the increase in the concentration of urea and LDH is explained by the adaptation of muscle metabolism to this oxygen deficiency.

FUNDING

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profits sectors.

摘要

背景

自因新冠疫情宣布进入警戒状态以来,医院一直是负责记录感染者治疗随访情况的主要机构。对这些数据的分析使得不同的生化标志物被确定为疾病严重程度的预测指标,但大多数已发表的研究往往极具描述性,并未提出生化假设来解释其所示结果的变化。我们的目标是识别新冠患者体内正在发生的主要代谢过程,以及确定对预测疾病严重程度起决定性作用的临床参数。

方法

对马德里 HM 医院数据库中收集的临床参数进行多变量分析,以确定预测疾病严重程度最相关的变量。化学计量学方法允许通过应用 PLS-LDA 分类策略来获得这些变量。

研究结果与解读

对分离贡献最大的变量在男性中是年龄,在男女两性中是乳酸脱氢酶、尿素和 C 反应蛋白的浓度。由于肺部功能丧失导致的组织缺氧可能对肌肉组织造成特别严重的影响。炎症和组织损伤与乳酸脱氢酶和 C 反应蛋白的增加有关。肌肉量的减少以及尿素和乳酸脱氢酶浓度的增加可通过肌肉代谢对这种缺氧的适应来解释。

资金

本研究未获得公共、商业或非营利部门的资助机构提供的任何特定资助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/660a43fa0b55/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/569e21152bd4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/5b1f11c31c12/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/564b79a8afdd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/660a43fa0b55/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/569e21152bd4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/5b1f11c31c12/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/564b79a8afdd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f95a/10006675/660a43fa0b55/gr4.jpg

相似文献

1
Evaluation of risk factors for COVID-19 severity or death and their relationship to metabolic pathways.评估新冠病毒疾病严重程度或死亡的风险因素及其与代谢途径的关系。
Heliyon. 2023 Mar;9(3):e14161. doi: 10.1016/j.heliyon.2023.e14161. Epub 2023 Feb 28.
2
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
5
Diagnostic and early prognostic value of serum CRP and LDH levels in patients with possible COVID-19 at the first admission.血清 CRP 和 LDH 水平在首次入院疑似 COVID-19 患者中的诊断和早期预后价值。
J Infect Dev Ctries. 2021 Jun 30;15(6):766-772. doi: 10.3855/jidc.14072.
6
Analysis of Biochemical and Inflammatory Markers for Predicting COVID-19 Severity: Insights From a Tertiary Healthcare Institution of Eastern India.用于预测新冠病毒疾病严重程度的生化和炎症标志物分析:来自印度东部一家三级医疗机构的见解
Cureus. 2023 Jan 17;15(1):e33893. doi: 10.7759/cureus.33893. eCollection 2023 Jan.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Using Unsupervised Machine Learning to Identify Age- and Sex-Independent Severity Subgroups Among Patients with COVID-19: Observational Longitudinal Study.使用无监督机器学习在 COVID-19 患者中识别与年龄和性别无关的严重程度亚组:观察性纵向研究。
J Med Internet Res. 2021 May 27;23(5):e25988. doi: 10.2196/25988.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid.白细胞介素-6及其他与马德里COVID-19住院患者队列预后不良相关的生物标志物
Biomark Insights. 2021 May 24;16:11772719211013363. doi: 10.1177/11772719211013363. eCollection 2021.

引用本文的文献

1
Diagnosis, Severity, and Prognosis from Potential Biomarkers of COVID-19 in Urine: A Review of Clinical and Omics Results.尿液中新冠病毒潜在生物标志物的诊断、严重程度及预后:临床与组学结果综述
Metabolites. 2024 Dec 22;14(12):724. doi: 10.3390/metabo14120724.
2
Longitudinal NMR-Based Metabolomics Study Reveals How Hospitalized COVID-19 Patients Recover: Evidence of Dyslipidemia and Energy Metabolism Dysregulation.基于纵向 NMR 的代谢组学研究揭示了住院 COVID-19 患者的康复情况:血脂异常和能量代谢失调的证据。
Int J Mol Sci. 2024 Jan 26;25(3):1523. doi: 10.3390/ijms25031523.

本文引用的文献

1
Severe loss of mechanical efficiency in COVID-19 patients.COVID-19 患者的机械效率严重丧失。
J Cachexia Sarcopenia Muscle. 2021 Aug;12(4):1056-1063. doi: 10.1002/jcsm.12739. Epub 2021 Jun 8.
2
Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID-19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID-Spain study).2873 例住院 COVID-19 患者入院时的特征和实验室检查结果:调整后的实验室检查在多中心研究中的影响。西班牙的一项多中心研究(BIOCOVID-Spain 研究)。
Scand J Clin Lab Invest. 2021 May;81(3):187-193. doi: 10.1080/00365513.2021.1881997. Epub 2021 Feb 16.
3
Sarcopenia: An underlying treatment target during the COVID-19 pandemic.
肌肉减少症:COVID-19 大流行期间的潜在治疗靶点。
Nutrition. 2021 Apr;84:111104. doi: 10.1016/j.nut.2020.111104. Epub 2020 Dec 5.
4
A Case of Concomitant COVID-19 Infection-Induced Acute Respiratory Distress Syndrome and Diabetic Ketoacidosis: Another Challenge in Fluid Management.1例新型冠状病毒肺炎合并感染所致急性呼吸窘迫综合征和糖尿病酮症酸中毒病例:液体管理中的又一挑战
Cureus. 2020 Nov 30;12(11):e11805. doi: 10.7759/cureus.11805.
5
Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers.在 COVID-19 中体重减轻、营养不良和恶病质:事实与数据。
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):9-13. doi: 10.1002/jcsm.12674. Epub 2020 Dec 31.
6
Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations.COVID-19 会成为 ICU 患者恶病质的危险因素吗?叙述性综述和营养建议。
Br J Nutr. 2021 Aug 28;126(4):552-560. doi: 10.1017/S0007114520004420. Epub 2020 Nov 5.
7
COVID-19 infection and the kidney.新型冠状病毒肺炎感染与肾脏
Br J Hosp Med (Lond). 2020 Oct 2;81(10):1-8. doi: 10.12968/hmed.2020.0574. Epub 2020 Oct 6.
8
SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染会使血清的代谢组学和脂质组学特征失调。
iScience. 2020 Oct 23;23(10):101645. doi: 10.1016/j.isci.2020.101645. Epub 2020 Oct 5.
9
Hospital Course of a Man With Viral Pneumonia Caused by COVID-19.一名由新冠病毒引起的病毒性肺炎男性患者的住院病程
Cureus. 2020 Jul 18;12(7):e9261. doi: 10.7759/cureus.9261.
10
Pulmonary function in patients surviving to COVID-19 pneumonia.新冠肺炎幸存患者的肺功能。
Infection. 2021 Feb;49(1):153-157. doi: 10.1007/s15010-020-01474-9. Epub 2020 Jul 28.